EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Outcomes of transmediastinal esophagectomy for patients with esophagogastric junction cancers

Kotaro Sugawara, Koichi Yagi, Shoh Yajima, Yoshiyuki Miwa, Shuichiro Oya, Asami Okamoto, Haruki Kojima, Raito Asaoka, Yoshifumi Baba

International Journal of Clinical Oncology · 2026-08 · 31 (8) · 1587-1596

DOI: 10.1007/s10147-026-03068-1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Clinical Oncology, online erschienen am 27.05.2026. Verfasst von Kotaro Sugawara und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Surgery, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan. mayotic…. Hauptthemen laut MEDLINE: Esophagectomy, Esophagogastric Junction, Esophageal Neoplasms, Adenocarcinoma. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The University of Tokyo.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

We aimed to evaluate the outcomes of transmediastinal esophagectomy (TME) for esophagogastric junction cancer (EGJC) patients.

Methods

We retrospectively reviewed patients who underwent TME for EGJC (Siewert Type II) between 2018 and 2023. Robot-assisted TME was performed using a robotic surgical system (DaVinci). Postoperative complications, overall survival (OS) and disease-free survival (DFS) were investigated.

Results

The median length of esophageal invasion was 3 cm. Adenocarcinoma was the most common tumor in our series (71.1%). A robotic approach was used for 25 (65.8%) patients. The most frequent major complication was pneumonia (≥ Grade I, n = 12, 31.6%), followed by recurrent laryngeal nerve palsy (≥ Grade I, n = 6, 15.8%). The incidence of anastomotic leakage (≥ Grade II) was 5.3% ( n = 2). The 30-day mortality rate was 0%. The 3-year OS and DFS rates were 67.5 and 51.8%, respectively. The distribution of pathological LN metastases did not significantly demarcate OS curves ( P = 0.43), while significantly stratifying DFS curves ( P < 0.001). Patients with both mediastinal and abdominal LN metastases had very poor DFS (2-year DFS; 0%).

Conclusions

TME for EGJC can be performed safely without increasing complications such as severe anastomotic leakage and in-hospital death. The relatively high frequency of pneumonia should be considered.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EsophagectomyEsophagogastric JunctionEsophageal NeoplasmsAdenocarcinomaHumansFemaleMaleAgedMiddle AgedRetrospective StudiesPostoperative ComplicationsDisease-Free SurvivalRobotic Surgical ProceduresTreatment OutcomeLymphatic MetastasisAdult

Stichwörter der Autor:innen

Anastomotic leakageEsophagogastric junction cancerTransmediastinal esophagectomy

Autor:innen und Institutionen

  • Department of Gastrointestinal Surgery, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan. mayotic@hotmail.com.
  • Department of Gastrointestinal Surgery, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.

Förderung

  • The University of Tokyo

Zitieren

APA

Sugawara, K., Yagi, K., Yajima, S., Miwa, Y., Oya, S., Okamoto, A., Kojima, H., Asaoka, R., & Baba, Y. (2026). Outcomes of transmediastinal esophagectomy for patients with esophagogastric junction cancers. International Journal of Clinical Oncology, 31(8), 1587-1596. https://doi.org/10.1007/s10147-026-03068-1

Vancouver

Sugawara K, Yagi K, Yajima S, Miwa Y, Oya S, Okamoto A, et al. Outcomes of transmediastinal esophagectomy for patients with esophagogastric junction cancers. International Journal of Clinical Oncology. 2026;31(8):1587-1596. doi:10.1007/s10147-026-03068-1

BibTeX
@article{Sugawara2026,
  author = {Sugawara, Kotaro and Yagi, Koichi and Yajima, Shoh and Miwa, Yoshiyuki and Oya, Shuichiro and Okamoto, Asami and Kojima, Haruki and Asaoka, Raito and Baba, Yoshifumi},
  title = {Outcomes of transmediastinal esophagectomy for patients with esophagogastric junction cancers},
  journal = {International Journal of Clinical Oncology},
  year = {2026},
  volume = {31},
  number = {8},
  pages = {1587--1596},
  doi = {10.1007/s10147-026-03068-1}
}
Kostenlos starten →